Results 81 to 90 of about 5,721 (196)
International Journal of Hypertension, 2017 Background. High value of neutrophil lymphocyte ratio (NLR) is a strong independent predictor and biomarker of ongoing vascular inflammation in various cardiovascular disorders. Objective.
Mazhar Hussain +4 more
doaj +1 more source
Topical effects of nebivolol on wounds in diabetic rats [PDF]
, 2012 Objective: Recently, it has reported that nebivolol might be useful in the treatment of diabetes mellitus foot ulcers. The aim of this study was to examine treatment of the wounds in streptozotocin-induced diabetic rats with topical ...
ÇAYCI, MUHAMMET KASIM +9 more
core +1 more source
Pulmonary effects of nebivolol
Therapeutic Advances in Cardiovascular Disease, 2009 The pharmacological control of arterial hypertension is a very frequent issue in clinical practice and some critical aspects can arise in particular circumstances and with particular molecules. In the case of hypertensive subjects with respiratory comorbidities, when first introduced, these β-adrenergic receptor antagonists were described as affecting
openaire +2 more sources
Proteomic profiling during atherosclerosis progression: Effect of nebivolol treatment
, 2009 There is a great need for the identification of biomarkers for the early diagnosis of atherosclerosis and the agents to prevent its progression. The aim of this study was to explore the effect of 24 week of nebivolol (a third-generation vasodilatory beta-
Ozben B +6 more
core +2 more sources
Nebivolol: Selektiver β1-Rezeptorenblocker mit NO-Modulierender Vasodilatation
, 2005 Nebivolol is a selective cardiac receptor antagonist, which mediates the release of endothelial nitric oxide (NO) and provides protection for the arteries and organs. Nebivolol improves the endothelial dysfunction and reduces the heart rate: owing to the
Paul Erne, Christiane Brockes
core +1 more source
Al-Mustansiriyah Journal of Pharmaceutical SciencesLiver injury can arise post-exposure to drugs or their metabolites, as well as herbal and dietary supplements. Tamoxifen is a frequently used drug in breast cancer treatment.
Noor Ahmed Hammadi +2 more
doaj +1 more source
Arterial stiffness, hypertension, and rational use of nebivolol
, 2009 Enrico Agabiti-Rosei, Enzo Porteri, Damiano RizzoniClinica Medica, Department of Medical and Surgical Sciences, University of Brescia, ItalyAbstract: Arterial stiffness plays a key role in the pathophysiology of the cardiovascular system. Some indices of
Damiano Rizzoni +5 more
core
Characterization of nitric oxide release by nebivolol and its metabolites.
, 2006 BACKGROUND: Nebivolol is a selective beta(1)-adrenergic receptor antagonist that causes a direct vasodilator effect attributed to the action on vascular nitric oxide (NO).
Lembo G. +21 more
core +1 more source
Use of nebivolol in patients with mild and moderate hypertensive disease
Терапевтический архив, 2003 Aim. To evaluate the effectiveness and safety of the beta-adrenoblocker nebivolol in patients with mild and moderate essential hypertension. Material and methods. The trial enrolled 20 patients.
L V Zhigunova, Ye L Lakhova, A P Yurenev
doaj
КардиоСоматика, 2013 Objective: to evaluate the antihypertensive efficacy and effect of nebivolol and valsartan on metabolic parameters and erective function in patients with hypertension, metabolic syndrome, and erectile dysfunction. Subjects and methods.
S. V Nedogoda +5 more
doaj